Mylan-Perrigo war of words heats up

Perrigo Co. plc accused generic drug giant Mylan NV of threatening to delist Perrigo from “every stock exchange, even if 49 percent of our holders say no to its offer,” President and CEO Joseph Papa wrote in a letter to shareholders Tuesday. Mylan’s pursuit of Perrigo has “further highlighted some very troubling corporate governance values,” Papa wrote. One example was Mylan’s decision to lower its acceptance condition to 50-plus percent of Perrigo’s outstanding shares from 80 percent,…